Influenza is a severe contagious disease caused by influenza A and B viruses. The WHO
estimates that annual outbreaks lead to 3–5 million severe infections of which approximately …

Influenza viruses are a leading cause of morbidity and mortality worldwide despite the
availability of an effective vaccine. The emergence of highly pathogenic avian influenza …

Influenza virus infection is a major source of morbidity and mortality worldwide. Due to the
variable effectiveness of existing vaccines, especially in the early stages of an epidemic …

Please cite this paper as: Wathen et al.(2012) Antivirals in seasonal and pandemic influenza—
future perspectives. Influenza and Other Respiratory Viruses 7 (Suppl. 1), 76–80. Antiviral …

The influenza virus represents a permanent global health threat because it circulates not
only within but also between numerous host populations, thereby frequently causing …

Viral pneumonia has been a serious threat to global health, especially now we have
dramatic challenges such as the COVID-19 pandemic. Approximately six million cases of …

In the advent of an influenza virus pandemic it is likely that the administration of antiviral
drugs will be an important first line of defence against the virus. The drugs currently in use …

Influenza A and B viruses are among the most prominent human respiratory pathogens.
About 3–5 million severe cases of influenza are associated with 300 000–650 000 deaths …

The recent avian influenza outbreaks underscore the importance of improving our
preparedness for an impending influenza pandemic. Various strategies, including …

Antivirals are effective in the prophylaxis and therapy of influenza and are likely to be active
against a new pandemic variant. They can be divided into the M2 inhibitors, amantadine and …